Twist BioscienceTWST
About: Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well-plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies and powers cost-effective, rapid high-throughput synthesis, enabling researchers to realize opportunities ahead rapidly. Geographically, it derives a majority of its revenue from the United States.
Employees: 923
Fund manager confidence
Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)
193% more call options, than puts
Call options by funds: $5.94M | Put options by funds: $2.02M
17% more repeat investments, than reductions
Existing positions increased: 90 | Existing positions reduced: 77
3.67% less ownership
Funds ownership: 120.36% [Q2] → 116.69% (-3.67%) [Q3]
7% less funds holding
Funds holding: 261 [Q2] → 242 (-19) [Q3]
11% less capital invested
Capital invested by funds: $3.45B [Q2] → $3.09B (-$363M) [Q3]
32% less first-time investments, than exits
New positions opened: 34 | Existing positions closed: 50
50% less funds holding in top 10
Funds holding in top 10: 2 [Q2] → 1 (-1) [Q3]
Research analyst outlook
6 Wall Street Analysts provided 1 year price targets over the past 3 months
6 analyst ratings
Scotiabank Sung Ji Nam 43% 1-year accuracy 9 / 21 met price target | 37%upside $62 | Sector Outperform Maintained | 4 Feb 2025 |
JP Morgan Rachel Vatnsdal 61% 1-year accuracy 11 / 18 met price target | 11%downside $40 | Underweight Maintained | 4 Feb 2025 |
Baird Catherine Ramsey 85% 1-year accuracy 11 / 13 met price target | 20%upside $54 | Outperform Maintained | 4 Feb 2025 |
Wolfe Research Doug Schenkel 40% 1-year accuracy 2 / 5 met price target | 33%upside $60 | Outperform Initiated | 13 Dec 2024 |
TD Cowen Steven Mah 80% 1-year accuracy 4 / 5 met price target | 28%upside $58 | Buy Reiterated | 26 Nov 2024 |
Financial journalist opinion
Based on 8 articles about TWST published over the past 30 days









